Measles

Debate between Maria Caulfield and Maggie Throup

Monday 22nd January 2024 Commons Chamber

[Maria Caulfield]

The hon. Lady is right that we used community champions during covid. We had some particularly effective campaigns for those communities that do not traditionally come forward for vaccinations, and that was done by using community leaders, faith leaders and trusted organisations within communities. We are doing that in the west midlands, in London and across the country.

Those people tell us that one of the key things that prevents Jewish and Muslim communities in particular from coming forward is their fear about the porcine vaccine. Just to reiterate, we have two types of MMR vaccine. Priorix does not contain gelatine and is safe and effective as an MMR vaccine. It is available on request, but we are also pushing out its availability so that people do not have to request it and it is offered up front. It is important that people know we have sufficient supply of the gelatine-free MMR product, and faith leaders, community groups and organisations are trying to get that message out to those two particular groups.

[Maggie Throup (Erewash) (Con)]

My hon. Friend has an important message today because, after clean water, vaccines are the most impactful public health measure we have and, without a doubt, they save lives. One of the lessons we learned through the pandemic was that the most effective way to reach hard-to-reach communities is through faith and community leaders and to take the vaccines to those communities, whether that is to mosques or temples. Will she do whatever she can to ensure that we employ the same measures this time and take the vaccines to the communities and not expect the communities to go to the vaccines? Will she also consider reaching out to those fantastic vaccinators we had during the covid pandemic, who are highly trained to deliver vaccines to all age groups, and getting them on board to get the MMR vaccinations carried out as quickly as possible?

[Maria Caulfield]

My hon. Friend is absolutely right. I pay tribute to the work she did during the covid pandemic to roll out the vaccine programme to those community groups. That had such an effective reach for something we were struggling with previously, and she worked hard on that. That is exactly what we are trying to replicate with this roll-out, and we are working with community groups and faith leaders, but also taking the vaccine out to communities. I was on the call with the London teams on Friday, and they have a vaccine bus that they are taking out to community centres and faith groups so that people do not have to book an appointment to get the vaccine. It is important to say that this is not just for children. If an adult has not had their vaccine, it is never too late to get the MMR vaccine to protect themselves against measles.

Oral Answers to Questions

Debate between Maria Caulfield and Maggie Throup

Wednesday 25th October 2023 Commons Chamber

[Maggie Throup (Erewash) (Con)]

11. What steps the Government are taking to help support women in STEM roles.

[The Minister for Women (Maria Caulfield)]

We have made great progress in increasing the number of girls studying STEM—science, technology, engineering and maths—subjects. Our challenge now is to do more to get them into STEM jobs. To support that, we launched a scheme called STEM returners, as one of our programmes to grow the skills of people who have taken a career break. We have so far had 42 women in our first cohort and 54 have signed up for our second cohort, getting women with experience and skills back into STEM jobs.

[Maria Caulfield]

I thank my hon. Friend for his work, particularly around promoting the energy sector across the United Kingdom. We are making progress on trying to get women and girls into that vital sector. One of our Build Back Better campaigns is seeking to inspire women from all walks of life to work in the green energy economy and raise awareness of green education, training and careers. My colleague the Minister with responsibility for employment and I regularly meet devolved colleagues to discuss how we can have a United Kingdom approach to this issue.

[Maggie Throup]

Last week I met a group of life science apprentices, young women and young men, who have taken up some great opportunities with STEM employers. One issue they raised with me was the lack of information about non-trade apprenticeships when they were considering their career options. What more can my hon. Friend do to promote STEM apprenticeships for the 16 to 18-year-olds who may not want to pursue the university route?

[Maria Caulfield]

My hon. Friend is a shining example of how women can lead in the STEM sector, with her own experience in clinical care before she came to this place. We are trying to drive forward apprenticeships, particularly in STEM subjects. Since May 2010, over 5 million apprenticeship starts have happened and our apprenticeship diversity champions are helping those aged 16 and over to get into apprenticeships, particularly in STEM subjects. Organisations such as UCAS and Young Women’s Trust are also doing that specific work.

Oral Answers to Questions

Debate between Maria Caulfield and Maggie Throup

Tuesday 24th January 2023 Commons Chamber

[Maria Caulfield]

Can I just reassure the hon. Lady that we take sexual health services very seriously? Local authorities in England have received more than £3 billion from Government to support those services. We have produced a number of plans to improve sexual and reproductive health, from the HIV action plan in 2021 to the women’s health strategy, which focuses on sexual health as well.

[Maggie Throup (Erewash) (Con)]

The all-party group for diagnostics will hold its inaugural meeting on 8 February, and plans to conduct a short inquiry with the aim of providing a blueprint for how community diagnostic centres should operate in the longer term. As part of the inquiry, will my right hon. Friend commit to meeting members of the group to discuss what more the Government can do to maximise the role of diagnostics in addressing the pressures on the NHS?

Oral Answers to Questions

Debate between Maria Caulfield and Maggie Throup

Tuesday 6th December 2022 Commons Chamber

[Maria Caulfield]

As the hon. Gentleman knows, I cannot comment on what is happening in Northern Ireland, because health is a devolved matter. I can only update him on what is happening in England. We are not waiting for a cancer plan to start on the backlogs: that is why this Government are investing £8 billion over three years to clear the elective backlog. We are seeing record numbers of patients. Cancer treatments continued throughout the pandemic, but we are seeing a higher number coming through than usual. Despite the increase of more than 129% in patients getting urgent GP referrals since September 2019, 91% of patients in England are receiving their treatment within 31 days of the decision to treat, compared with just 87% of patients in Northern Ireland in June. We are very committed to reducing cancer waiting times. I suggest that the hon. Gentleman may wish to speak to the Minister in Northern Ireland as well.

[Maggie Throup (Erewash) (Con)]

Diagnostic activity, whether in vivo or in vitro, forms part of more than 85% of clinical pathways. Will my hon. Friend confirm that it will receive due recognition in the 10-year cancer strategy?

[Maria Caulfield]

May I thank my hon. Friend for all her hard work during her time as a Health Minister? We are going through the responses to the call for evidence right now; as I have indicated, we will update the House shortly. I will very much take her points on board.